These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 23157826)
1. [Correlation between KRAS mutations and clinicopathologic features in colorectal carcinomas]. Gao J; Zhang J; Lu T; Li XY; Jia N; Liang ZY Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):595-8. PubMed ID: 23157826 [TBL] [Abstract][Full Text] [Related]
2. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas]. Zhang X; Wang Y; Gao N; Wang J Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565 [TBL] [Abstract][Full Text] [Related]
3. [Correlation of KRAS gene mutations and clinicopathologic parameters in colorectal carcinoma]. Wang Q; Zhong M; Lü YL; Yuan J; Wei LX Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):603-6. PubMed ID: 23157828 [TBL] [Abstract][Full Text] [Related]
4. [Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases]. Gao J; Sun ZW; Li YY; Shen L Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):579-83. PubMed ID: 23157823 [TBL] [Abstract][Full Text] [Related]
5. [KRAS gene somatic mutations in Chilean patients with colorectal cancer]. Hurtado C; Encina G; Wielandt AM; Zárate AJ; Castro M; Carrillo K; Kronberg U; López-Köstner F Rev Med Chil; 2014 Nov; 142(11):1407-14. PubMed ID: 25694286 [TBL] [Abstract][Full Text] [Related]
6. [Detection of KRAS gene mutation and its clinical significance in colorectal adenocarcinoma]. Xu C; Liu YL; Huang J; He DM; Hou YY; Ji Y; Hou J; Lu SH; Xu JF; Hu Q; Shi Y; Zhao LJ; Tan YS Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):667-70. PubMed ID: 23302307 [TBL] [Abstract][Full Text] [Related]
7. [KRAS gene mutation in colorectal cancer]. Roa I; Sánchez T; Majlis A; Schalper K Rev Med Chil; 2013 Sep; 141(9):1166-72. PubMed ID: 24522420 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma. Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059 [TBL] [Abstract][Full Text] [Related]
9. Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer. Neumann J; Zeindl-Eberhart E; Kirchner T; Jung A Pathol Res Pract; 2009; 205(12):858-62. PubMed ID: 19679400 [TBL] [Abstract][Full Text] [Related]
10. Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis. Margonis GA; Kim Y; Spolverato G; Ejaz A; Gupta R; Cosgrove D; Anders R; Karagkounis G; Choti MA; Pawlik TM JAMA Surg; 2015 Aug; 150(8):722-9. PubMed ID: 26038887 [TBL] [Abstract][Full Text] [Related]
11. [KRAS and BRAF gene mutations in correlation with clinicopathologic features of colorectal carcinoma in Chinese]. Zhu XL; Cai X; Zhang L; Yang F; Sheng WQ; Lu YM; Du X; Zhou XY Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):584-9. PubMed ID: 23157824 [TBL] [Abstract][Full Text] [Related]
12. [The frequency and spectrum of KRAS mutations in metastatic colorectal cancer]. Mazurenko NN; Gagarin IM; Tsyganova IV; Mochal'nikova VV; Breder VV Vopr Onkol; 2013; 59(6):751-5. PubMed ID: 24624786 [TBL] [Abstract][Full Text] [Related]
13. Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosis. Bouchahda M; Karaboué A; Saffroy R; Innominato P; Gorden L; Guettier C; Adam R; Lévi F Cancer Chemother Pharmacol; 2010 Aug; 66(3):605-9. PubMed ID: 20361188 [TBL] [Abstract][Full Text] [Related]
14. Characterization of rare transforming KRAS mutations in sporadic colorectal cancer. Tong JH; Lung RW; Sin FM; Law PP; Kang W; Chan AW; Ma BB; Mak TW; Ng SS; To KF Cancer Biol Ther; 2014 Jun; 15(6):768-76. PubMed ID: 24642870 [TBL] [Abstract][Full Text] [Related]
15. KRAS gene mutation in a series of unselected colorectal carcinoma patients with prognostic morphological correlations: a pyrosequencing method improved by nested PCR. de Macêdo MP; de Melo FM; Lisboa BC; Andrade LD; de Souza Begnami MD; Junior SA; Ribeiro HS; Soares FA; Carraro DM; da Cunha IW Exp Mol Pathol; 2015 Jun; 98(3):563-7. PubMed ID: 25835782 [TBL] [Abstract][Full Text] [Related]
16. KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma. Pang NK; Nga ME; Chin SY; Ismail TM; Lim GL; Soong R; Salto-Tellez M Cytopathology; 2011 Dec; 22(6):358-64. PubMed ID: 21029218 [TBL] [Abstract][Full Text] [Related]
17. KRAS and BRAF mutations in Serbian patients with colorectal cancer. Jakovljevic K; Malisic E; Cavic M; Krivokuca A; Dobricic J; Jankovic R J BUON; 2012; 17(3):575-80. PubMed ID: 23033302 [TBL] [Abstract][Full Text] [Related]
18. [Detection of KRAS, BRAF, PIK3CA and EGFR gene mutations in colorectal carcinoma]. Ling Y; Ying JM; Qiu T; Shan L; Guo L; Lü N Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):590-4. PubMed ID: 23157825 [TBL] [Abstract][Full Text] [Related]
19. KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma. Siyar Ekinci A; Demirci U; Cakmak Oksuzoglu B; Ozturk A; Esbah O; Ozatli T; Celik B; Budakoglu B; Turker I; Bal O; Turan N J BUON; 2015; 20(1):128-35. PubMed ID: 25778307 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation. Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]